admin
The first Camp Lejeune Track‑1 trial — Mousser v. United States — opens on October 26, 2026, and it promises to be more than a fact‑finder for one family. It will be a real test of the Justice Department’s two‑track strategy: a public rush to pay Elective Option settlements while the same DOJ turns around and fights other claims in court with a single government expert whose late tinkering was rejected by a judge. That split personality deserves scrutiny, and so do the people who run the system.
The Mousser trial: the courtroom trial that matters
Mousser is the first bench trial that will squarely test whether the government can credibly deny general causation for the illnesses the VA already treats as presumptively tied to Camp Lejeune. The government’s go‑to expert is Dr. Julie Goodman, whose Phase II reports were filed in February 2025. Then the government tried to slip in roughly 300 changes months later — changes Magistrate Judge Robert B. Jones Jr. struck from the record as untimely. The trial judge assigned to Mousser is Judge Terrence W. Boyle, and how he treats the Goodman testimony could tilt the entire litigation landscape. Simple truth: if your expert’s work gets an emergency “undo” stamp from the court, you don’t look like the side with a slam dunk.
Settling with one hand, litigating with the other
Meanwhile, the Department of Justice has been fast‑tracking Elective Option offers to thousands of claimants, approving hundreds of offers in a matter of weeks and publicly touting hundreds of millions in payouts. Associate Attorney General Stanley Woodward told Americans the DOJ has reprioritized approvals and is pushing settlements weekly. President Trump even used a campaign rally to trumpet what he called $1 billion in cash settlements and to promise a directive to finish remaining legitimate claims if Republicans hold Congress. There’s nothing wrong with settling claims efficiently — veterans deserve timely relief — but paying some people while aggressively litigating others creates the appearance of a Washington ledger book, not a justice system.
Who wins when DOJ plays both sides?
That split approach creates immediate questions. Are Elective Option amounts fair, or are they cheap pressure to keep the tab down? Why is the government offering payments to one cohort while betting the farm in court on shaky expert proof for another? Plaintiffs’ lawyers say many eligible veterans reject EO offers as too low; taxpayers and budget watchers point to multibillion‑dollar potential exposure. The Mousser trial will influence settlement leverage across thousands of cases. If the government’s scientific case is weakened by procedural missteps — like late changes to expert tables — plaintiffs gain bargaining power. If the government prevails, that could cut payouts even more deeply. Veterans deserve neither gamesmanship nor half‑measures.
The fix is simple: be consistent and transparent. If settling is the right policy, finish it with clear criteria and fair numbers. If litigation is the path, put forward airtight evidence and play by the court’s rules — not last‑minute “patches” that look like a software update to dodge scrutiny. Republicans in Congress who want these claims resolved should insist on both fairness for veterans and accountability for how DOJ litigates. And if President Trump wants the job done, he should keep pushing — but demand that the Justice Department stop treating veterans like chess pieces and start treating them like Americans who earned better than delays and mixed signals.
